Oral edaravone for patients with amyotrophic lateral sclerosis (ALS) is safe through a total of 144 weeks with no new safety signals observed. Among patients with amyotrophic lateral sclerosis ...

The New England Journal of Medicine (NEJM) published positive results from the HERCULES phase 3 study demonstrating that tolebrutinib delayed disability progression in people with non-relapsing ...

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with their disorder, a new clinical trial suggests. The drug, tolebrutinib ...

26, 2023, in Los Angeles, California. Applegate went public with her multiple sclerosis diagnosis in 2021. She now co-hosts a podcast about life with MS, called “MeSsy,” alongside actor Jamie-Lynn ...

I remember the day of my relapsing-remitting multiple sclerosis diagnosis, when I didn’t understand the weight of what I’d been told. I was only 17 years old and didn’t know what questions ...

Christina Applegate got emotional opening up about her struggle with multiple sclerosis, nearly four years after she was first diagnosed. “I am defined by it right now,” the actor said during ...

The government plans to install reverse osmosis packaged units to treat toxic acid mine drainage (AMD) to optimise the use of water and to help alleviate water stress in Gauteng. The department of ...

(NASDAQ: TGTX), today announced the presentation of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of multiple sclerosis (RMS), at the American Academy of ...

A new study published in Multiple Sclerosis and Related Disorders highlights the potential of "More Stamina," a gamified mobile health (mHealth) app designed to help people with multiple sclerosis ...

Throughout the course of multiple sclerosis, gradually progressive neurologic impairment can occur, which has been called disability accrual. Current disease-modifying therapies for multiple ...

Get Instant Summarized Text (Gist) New therapeutic targets for multiple sclerosis (MS) tissue recovery have been identified, potentially leading to treatments that promote myelin repair. Current ...

More data are needed on its efficacy and safety in treating relapsing multiple sclerosis. In two phase 3, double-blind, double-dummy, event-driven trials (GEMINI 1 and GEMINI 2), participants with ...